However, despite the remarkable effectiveness in restoring the channel’s functions, CFTR modulators are unable to eradicate bacterial infections, especially in CF patients with irreversible lesions of the lung structure and/or bronchiectasis [20]. The gene discussed is CFTR; the disease is cystic fibrosis.